Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice

Epstein–Barr virus strain heterogeneity impairs human T-cell immunity

(2018) Ana Cirac et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus

(2018) Joost Snijder et al.   IMMUNITY

Translational profiling of B cells infected with the Epstein-Barr virus reveals 5′ leader ribosome recruitment through upstream open reading frames

(2018) Maja Bencun et al.   NUCLEIC ACIDS RESEARCH

Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry

(2018) Hua Zhang et al.   Nature Microbiology

Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus

(2018) Jia Chen et al.   Nature Microbiology

Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection

(2018) Calum Forrest et al.   PLoS Pathogens

Epstein–Barr virus particles induce centrosome amplification and chromosomal instability

(2017) Anatoliy Shumilov et al.   Nature Communications

Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination

(2016) Jill M. Brooks et al.   PLoS Pathogens

The Immunology of Epstein-Barr Virus–Induced Disease

(2015) Graham S. Taylor et al.   Annual Review of Immunology

Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cells

(2015) X. Yu et al.   BLOOD

Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site

(2015) Masaru Kanekiyo et al.   CELL

A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice

(2015) Javier Ogembo et al.   Journal of Translational Medicine

The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells

(2015) Xiaochen Lin et al.   PLoS Pathogens

Epstein–Barr virus replicating in epithelial cells

(2014) Lindsey M. Hutt-Fletcher   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Virus and Autoantigen-Specific CD4+ T Cells Are Key Effectors in a SCID Mouse Model of EBV-Associated Post-Transplant Lymphoproliferative Disorders

(2014) Stefanie Linnerbauer et al.   PLoS Pathogens

KSHV 2.0: A Comprehensive Annotation of the Kaposi's Sarcoma-Associated Herpesvirus Genome Using Next-Generation Sequencing Reveals Novel Genomic and Functional Features

(2014) Carolina Arias et al.   PLoS Pathogens

Epstein-Barr Virus in Systemic Autoimmune Diseases

(2013) Anette Holck Draborg et al.   Clinical & Developmental Immunology

Detection of Epstein-Barr virus-specific memory CD4+T cells using a peptide-based cultured enzyme-linked immunospot assay

(2013) Sandra A. Calarota et al.   IMMUNOLOGY

CD8+ T Cell Responses to Lytic EBV Infection: Late Antigen Specificities as Subdominant Components of the Total Response

(2013) R. J. M. Abbott et al.   JOURNAL OF IMMUNOLOGY

Spontaneous Lytic Replication and Epitheliotropism Define an Epstein-Barr Virus Strain Found in Carcinomas

(2013) Ming-Han Tsai et al.   Cell Reports

An Epstein-Barr Virus Mutant Produces Immunogenic Defective Particles Devoid of Viral DNA

(2012) S. Pavlova et al.   JOURNAL OF VIROLOGY

The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection

(2011) Josef Mautner et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Immunotherapy for EBV-associated malignancies

(2011) Anna Merlo et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

New flow cytometric assays for monitoring cell-mediated cytotoxicity

(2010) Liubov Zaritskaya et al.   Expert Review of Vaccines

How I treat EBV lymphoproliferation

(2009) H. E. Heslop   BLOOD

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

(2009) Till Strowig et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Primary B-Cell Infection with a  BALF4 Epstein-Barr Virus Comes to a Halt in the Endosomal Compartment yet Still Elicits a Potent CD4-Positive Cytotoxic T-Cell Response

(2009) B. Neuhierl et al.   JOURNAL OF VIROLOGY

Human antibody titers to Epstein–Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay

(2009) Junji Sashihara et al.   VIROLOGY

Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses

(2008) C. Gurer et al.   BLOOD

A New Humanized Mouse Model of Epstein‐Barr Virus Infection That Reproduces Persistent Infection, Lymphoproliferative Disorder, and Cell‐Mediated and Humoral Immune Responses

(2008) Misako Yajima et al.   JOURNAL OF INFECTIOUS DISEASES

Standardized and Highly Efficient Expansion of Epstein-Barr Virus-Specific CD4+ T Cells by Using Virus-Like Particles

(2008) D. Adhikary et al.   JOURNAL OF VIROLOGY